Sartorius AG (0NIQ) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Sartorius Ag.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.320 Welcome to the presentation of Sartorius and Sartorius Stadium Biotech's 9-month 00:00:05.320 -- 00:00:07.764 2025 results. 00:00:07.764 -- 00:00:13.233 Please note that the call is being recorded and streamed on Sartorius' website. 00:00:13.233 -- 00:00:17.380 Your participation in this implies your consent with this. 00:00:17.380 -- 00:00:21.026 A replay will be available shortly after the call. 00:00:21.026 -- 00:00:25.814 I would now like to turn the conference over to Petra Müller, Head of Investor Relations 00:00:25.814 -- 00:00:27.914 of Sartorius. 00:00:28.398 -- 00:00:31.542 Hello, thank you, Matilda, and a warm welcome from my side. 00:00:31.542 -- 00:00:36.628 I'm joined today by our CEO, Michael Große, by Florian Funk, our CFO, 00:00:36.628 -- 00:00:41.314 by René Faber, head of our Bioprocessing Division and CEO of Sartorial State and Biotech, 00:00:41.314 -- 00:00:45.900 and by Alexandra Gatzemeier, head of our Lab Products and Services Division. 00:00:45.900 -- 00:00:50.065 As always, we will start with prepared remarks followed by a Q&A session. 00:00:50.065 -- 00:00:54.330 As the call is scheduled for one hour, please limit your questions to two so that as 00:00:54.330 -- 00:00:57.203 many participants as possible can take part. 00:00:57.203 -- 00:01:01.149 Please note that management comments during this call will include forward-looking statements 00:01:01.149 -- 00:01:05.617 that involve risks and uncertainties for discussion of the risk factors. 00:01:05.617 -- 00:01:10.785 I encourage you to review the safe harbor statement contained in our today's documents. 00:01:10.785 -- 00:01:15.914 All of these are relating to our nine-month figures, and the reporting are available 00:01:15.914 -- 00:01:20.942 on the web...